Butyrate Research Guide

Full name: Sodium Butyrate / Tributyrin

A short-chain fatty acid (SCFA) that is the primary energy source for colonocytes. Produced by gut bacteria from fiber fermentation, supplemental butyrate supports intestinal barrier integrity, reduces inflammation, and promotes healthy gut microbiome composition.

How Butyrate Works

Inhibits histone deacetylases (HDACs) for anti-inflammatory gene expression. Fuels colonocyte mitochondria via beta-oxidation. Strengthens tight junctions by upregulating claudin-1 and ZO-1. Activates GPR109A to suppress NF-κB.

Dosing Protocol

• Typical dose: 300-600 mg tributyrin or 500-2000 mg sodium butyrate
• Frequency: 2-3x daily with meals
• Duration: Ongoing
• Route: Oral (enteric-coated or tributyrin pro-drug)

Reported Benefits

• Colonocyte energy support
• Tight junction integrity
• Reduced GI inflammation
• Healthy microbiome support
• Epigenetic modulation (HDAC inhibition)
• Improved insulin sensitivity

Potential Side Effects

• GI gas/bloating
• Unpleasant taste/odor (sodium butyrate)
• Loose stools initially
• Rare: heartburn

Research Citations

1. Butyrate and intestinal barrier function (2021) - Supplemental butyrate increased transepithelial resistance by 45% and reduced endotoxin translocation in human gut models.
2. Tributyrin in ulcerative colitis (2022) - 4-week tributyrin supplementation reduced fecal calprotectin by 60% and improved clinical remission rates in mild-moderate UC.

Related Gut Health Compounds

• Larazotide - Full Profile
• Colostrum - Full Profile
• BPC-157 Oral (Gut) - Full Profile
• Akkermansia - Full Profile
• Ovagen - Full Profile

View full Butyrate profile with 3D molecule viewer →